MNSB vs CARE

For growth investors, Carter Bankshares, Inc.

(CARE) is the stronger pick with 6. 2% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). MainStreet Bancshares, Inc. (MNSB) offers the better valuation at 13. 3x trailing P/E (10. 4x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, MainStreet Bancshares, Inc.

(MNSB) is the cheapest at 13. 3x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Carter Bankshares, Inc.

(CARE) delivered a total return of +88. 0%, compared to +18. 6% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: MNSB returned +128. 0% versus CARE's +111. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Carter Bankshares, Inc.

(CARE) is the lower-risk stock at 0. 56β versus MainStreet Bancshares, Inc. 's 0. 66β — meaning MNSB is approximately 18% more volatile than CARE relative to the S&P 500. On balance sheet safety, MainStreet Bancshares, Inc. (MNSB) carries a lower debt/equity ratio of 32% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Carter Bankshares, Inc.

(CARE) is pulling ahead at 6. 2% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 32. 1% for Carter Bankshares, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Carter Bankshares, Inc.

(CARE) is the more profitable company, earning 12. 3% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 12. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CARE leads at 15. 7% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — CARE leads at 61. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Carter Bankshares, Inc.

(CARE) trades at 4. 8x forward P/E versus 10. 4x for MainStreet Bancshares, Inc. — 5. 6x cheaper on a one-year earnings basis.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Carter Bankshares, Inc.

(CARE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 56), +111. 1% 10Y return). Both have compounded well over 10 years (CARE: +111. 1%, MNSB: +128. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: MNSB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.